Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Normal values for vaccine responses and lymphocyte subsets in adults older than 60 years
NL-OMON44308Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tetanus toxoid and 23-valent pneumococcal polysaccharide vaccine, sponsored by Amsterdam University Medical Center. Started Jun 2018; status: active, not recruiting.
02
Drugs
tetanus toxoid23-valent pneumococcal polysaccharide vaccine
Beyond the preview
Go deeper on NL-OMON44308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44308.